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Abstract
Background/Aims: TNF-α-mediated pro-inflammatory phenotypic change in monocytes 
is known to be implicated in the pathogenesis of metabolic inflammation and insulin 
resistance. However, the mechanism by which TNF-α-induces inflammatory phenotypic 
shift in monocytes is poorly understood. Since long-chain acyl-CoA synthetase 1 (ACSL1) is 
associated with inflammatory monocytes/macrophages, we investigated the role of ACSL1 
in the TNF-α-driven inflammatory phenotypic shift in the monocytes. Methods: Monocytes 
(Human monocytic THP-1 cells) were stimulated with TNF-α. Inflammatory phenotypic 
markers (CD16, CD11b, CD11c and HLA-DR) expression was determined with real time RT-
PCR and flow cytometry. IL-1β and MCP-1 were determined by ELISA. Signaling pathways 
were identified by using ACSL1 inhibitor, ACSL1 siRNA and NF-κB reporter monocytic cells. 
Phosphorylation of NF-κB was analyzed by western blotting and flow cytometry. Results: Our 
data show that TNF-α induced significant increase in the expression of CD16, CD11b, CD11c 
and HLA-DR. Inhibition of ACSL1 activity in the cells with triacsin C significantly suppressed 
the expression of these inflammatory markers. Using ACSL-1 siRNA, we further demonstrate 
that TNF-α-induced inflammatory markers expression in monocytic cells requires ACSL1. In 
addition, IL-1b and MCP-1 production by TNF-α activated monocytic cells was significantly 
blocked by the inhibition of ACSL-1 activity. Interestingly, elevated NF-κB activity resulting from 
TNF-α stimulation was attenuated in ACSL1 deficient cells. Conclusion: Our findings provide 
an evidence that TNF-α-associated inflammatory polarization in monocytes is an ACSL1 
dependent process, which indicates its central role in TNF-α-driven metabolic inflammation.
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Introduction
Chronic low-grade inflammation is a central characteristic of obesity and is involved in 
the development of insulin resistance in adipose tissue, muscle, and liver. This is caused by 
inflammatory mediators produced by activated circulatory and infiltrated immune cells in 
adipose tissue. Among the immune cells, monocytes/macrophages play an important role in 
obesity-induced adipose tissue inflammation. Monocytes (precursor cells of macrophages) 
isolated from obese humans display an inflammatory phenotype and secrete higher levels of 
pro-inflammatory cytokines/chemokines such as TNF-α, IL-6, IL-1b, and MCP-1 compared 
to monocytes from the lean individuals [1, 2]. Distinct monocyte subsets could be identified 
based on the expression of the surface antigen CD16. Classical monocytes do not express 
the CD16 antigen (CD14++CD16−), while “non-classical” monocytes express CD16 on the 
cell surface (CD14+CD16++). The expression pattern of the two surface markers reflect 
the function of the monocytes. It is well noted that monocytes/macrophages in obesity 
are polarized to more pro-inflammatory phenotype (M1).  The primary trigger for the 
recruitment of monocytes into the adipose tissue is thought to be the secretion of the 
chemokine; Monocyte chemoattractant protein-1 (MCP-1) by TNF-α-activated enlarged 
adipocytes. Pro-inflammatory monocytes/macrophages have high surface expression 
markers like CD14, CD16, CD11b, CD11c, and HLA-Dr [3, 4].
Increased circulating levels of TNF-α have been found in obese humans and rodents 
[5]. TNF-α action in obesity has been considered mainly inflammatory because it activates 
immune cells particularly monocytes and macrophages [6]. TNF-α plays a key role in shifting 
monocytes/macrophages into inflammatory state. However, the mechanism by which TNF-α 
induces this pro-inflammatory shift remains elusive. In obesity and type 2 diabetes (T2D), 
plasma and tissue levels of free fatty acids (FFAs) are elevated and have been suggested 
to contribute to the development of chronic inflammation and insulin resistance [7]. Since 
acyl-CoA synthetase 1 (ACSL1), which converts FFAs into their acyl-CoA derivatives, is 
involved in promoting inflammatory phenotype of the monocytes/macrophages associated 
diabetes [8], we hypothesized that ACSL1 could play a key role in the TNF- α mediated 
inflammatory polarization in monocytes. Here we show that blocking ACSL1 activity inhibits 
the expression of inflammatory markers in monocytes. ACSL1 deficient cells express less 
inflammatory markers in response to TNF-α. ACSL1 specific siRNA and its inhibitor also block 
the production of inflammatory mediators such as IL-1b and MCP-1. TNF-α-mediated NF-κB 
activity was also blocked in ACSL1 deficient cells. Collectively, our data show an interesting 
novel role of ACSL1 in TNF-α-driven inflammation.
Materials and Methods
Cell Culture
Monocytes, human monocytic THP-1 cells ,  were  purchased from American Type Culture Collection 
(ATCC) and grown in RPMI-1640 culture medium (Gibco, Life Technologies, Grand Island, USA) supplemented 
with 10% fetal bovine serum (Gibco, Life Technologies, Grand Island, NY, USA), 2 mM glutamine (Gibco, 
Invitrogen, Grand Island, NY, USA), 1 mM sodium pyruvate, 10 mM HEPES, 100 ug/ml Normocin, 50 U/ ml 
penicillin and 50 μg/ml streptomycin (P/S; (Gibco, Invitrogen, Grand Island, NY, USA), and incubation at 
37°C (with humidity) in 5% CO2. NF-кB reporter monocytic cells (THP-1-XBlue) stably expressing a secreted 
embryonic alkaline phosphatase (SEAP) reporter inducible by NF-κB were purchased from InvivoGen 
(InvivoGen, San Diego, CA, USA). THP-1-XBlueTM-defMyD cells (monocytes deficient in MyD88 activity 
or MyD88-/- monocytes) were purchased from InvivoGen (San Diego, CA, USA). THP-1-XBlue cells were 
cultured in complete RPMI medium with the addition of zeocin (200 μg/ml) to select for cells expressing the 
SEAP -NF-κB reporter (InvivoGen, San Diego, CA, USA). Prior to stimulation, monocytes were transferred to 
normal serum free medium and plated in 12-well plates (Costar, Corning Incorporated, Corning, NY, USA) at 
1 × 106 cells/well cell density unless indicated otherwise.
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Cell stimulation
Monocytes were plated in 12-well plates (Costar, Corning Incorporated, Corning, NY, USA) at 1 × 106 
cells/well concentration unless indicated otherwise. Cells were stimulated with TNF-α (10ng/ml) or LPS 
(10 ng/ml; Sigma, Saint Louis, MO, USA) or Vehicle (0.1% BSA) for 6-12 hrs at 37°C. Cells were harvested 
for RNA isolation and staining and culture media were collected for measuring IL-1b and MCP-1 secretion.
Real time quantitative RT-PCR
Total RNA was extracted using RNeasy Mini Kit (Qiagen, Valencia. CA, USA) per the manufacturer’s 
instructions. The cDNA was synthesized using 1μg of total RNA using high capacity cDNA reverse transcription 
kit (Applied Biosystems, Foster city, CA, USA). Real-time PCR was performed on 7500 Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA) using TaqMan® Gene Expression Master Mix (Applied 
Biosystems, Foster city). Each reaction contained 500ng cDNA that was amplified with Inventoried TaqMan 
Gene Expression Assay products (ITGAM: Hs00355885_m1; TNF: Hs01113624_g1; GAPDH: Hs03929097_
g1; HLA-DR: Hs00219575_m1; ACSL1: Hs00960561_m1). The threshold cycle (Ct) values were normalized 
to the house-keeping gene GAPDH and the amounts of target mRNA relative to control were calculated with 
ΔΔCt-method [9, 10]. Relative mRNA expression was expressed as fold expression over average of control 
gene expression. The expression level in control treatment was assumed to be 1. Values are presented as 
mean ± SEM. Results were analyzed statistically; P< 0.05 was considered significant.
Extracellular staining -flow cytometry
After different treatments, monocytic cells (1x106 cells) were resuspended in FACS staining buffer 
(BD Biosciences) and blocked with human IgG (Sigma; 20μg) for 30 minutes on ice. Cells were washed 
and resuspended in 100 ul of FACS buffer and incubated with CD16 (CB16)-APC (cat# 17-0168-42 ;BD 
Biosciences), CD11b (D12)-APC  (cat# 340936 ;BD Biosciences), CD11b-FITC (cat# IM0530U; Beckmen 
coulter), CD11c (S_HCL-3)-PE (cat# 347637 ;BD Biosciences) or HLA-DR-PE (cat# IM1639 ;Beckmen 
coulter) on ice for 30 minutes. Cells were washed three times with FACS buffer and resuspended in 2% 
paraformaldehyde. Cells were centrifuged and resuspended in FACS buffer for FACS analysis (FACSCanto 
II; BD Bioscience, San Jose, USA). FACS data analysis was performed using BD FACSDivaTM Software 8 (BD 
Biosciences, San Jose, USA)
Small interfering RNA (siRNA) transfections
Monocytes were washed and resuspended in 100 ul of nucleofector solution provided with the Amaxa 
Noclecfector Kit V and transfected separately with siRNA-ACSL1 (30nM; OriGene Technologies, Inc. MD, 
USA), scramble (control) siRNA (30nM; OriGene Technologies, Inc. MD, USA, USA), and pmaxGFP (0.5 ug; 
Amaxa Noclecfector Kit V for THP-1, Lonza). All transfection experiments were performed with Amaxa 
Cell Line Nucleofector Kit V for monocytic cells(Lonza, Germany) by using Amaxa Electroporation System 
(Amaxa Inc, Germany) according to the manufacturer’s protocol [11]. After 36 hours of transfection, cells 
were treated with TNF-α for 6-12 hours. Cells were harvested for RNA isolation and staining study. ACSL1 
gene knock down level was assessed by Real Time-PCR using ACSL1 gene specific primer probes.
IL-1b and MCP-1 determination
Secreted IL-1b and MCP-1 protein in supernatants of monocytic cells stimulated with TNF-α was 
quantified using sandwich ELISA following the manufacturer’s instructions (R&D systems, Minneapolis, 
USA).
Western blotting
Monocytic cells treated with TNF-α at different time points were harvested and incubated for 30 
minutes with lysis buffer (10X Lysis Buffer, Cell signaling, USA). The protein lysates were prepared and 
resolved by 12% SDS-PAGE as described earlier [12]. Cellular proteins were transferred to Immuno-Blot 
PVDF membrane (Bio-Rad Laboratories, USA) by electro blotting. The membranes were then blocked with 
5% non-fat milk in PBS for 1 hour, followed by incubation with primary antibodies against p-NF-кB and 
NF-кB in 1: 1000 dilution at 4°C overnight. All the primary antibodies were purchased from Cell Signalling 
(Cell Signalling Technology, Inc). The blots were then washed three times with TBS-T and incubated for 
2 hours with HRP-conjugated secondary antibody (Promega, Madison, WI, USA). Immunoreactive bands 
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were developed using an Amersham ECL Plus Western Blotting Detection System (GE Health Care, 
Buckinghamshire, UK) and visualized by Molecular Imager® VersaDocTM MP Imaging Systems (Bio-Rad 
Laboratories, Hercules, CA, USA).
Measurement of NF-κB activity
NF-кB reporter monocytes (THP-1 XBlue; InvivoGen, San Diego, CA) are stably transfected with a 
reporter construct, expressing a secreted embryonic alkaline phosphatase (SEAP) gene under the control 
of a promoter inducible by the transcription factors NF-κB. Upon stimulation, NF-κB is activated and 
subsequently the secretion of SEAP is stimulated. Cells were stimulated with TNF-α (10 ng/ml) for 6-12 
hours at 37°C. Levels of SEAP were detected in the culture media after 3 hours incubation of supernatants 
with Quanti-Blue solution (InvivoGen, San Diego, CA, USA) at 650nm wave length by ELISA reader [13].
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software (La Jolla, CA, USA). Data are shown 
as mean ± standard error of the mean, unless otherwise indicated. Unpaired Student t-test and one way 
ANOVA followed by tukey’s test were used to compare means between groups. For all analyses, data from a 
minimum of three sample sets were used for statistical calculation. P value <0.05 was considered significant. 
Ns: no significance, *P < 0.05, ** P<0.01, *** P< 0.001 and **** P < 0.0001)
Results
Inhibition of ACSL1 suppresses the TNF-α induced pro-inflammatory phenotypic shift in 
monocytes
To query whether ACSL1 was required for TNF-α-mediated activation of monocytes, 
we used triacsin c to inhibit ACSL1 expression in monocytes (Fig. 1A) and measured the 
phenotypic inflammatory markers expression in these cells. Our data show that pretreatment 
of the monocytes with triacsin c, followed by the exposure to TNF-α, caused a significant 
suppression in the expression of inflammatory marker CD16 (Fig. 1B and C). In the case of 
obesity setting, CD11c is abundantly expressed in monocytes and macrophages [14]. We 
found that TNF-α upregulates the expression of CD11c at both mRNA and protein levels in 
monocyes. Inhibition of ACSL1 significantly blocks the expression of CD11c in monocyes 
(Fig. 1D-F).  Since CD11b and HLA-DR cell surface are considered phenotypic markers for 
inflammatory monocytes, we also found that TNF-α-induced CD11b and HLA-DR expression 
in monocytes were blocked by inhibition of ACSL1 (Fig. 1G-L).
Activated monocytes/macrophages play a role in the pathogenesis of the different 
diseases by secreting inflammatory cytokines. Therefore, we questioned whether TNF-α-
mediated activation of monocytes led to the production of IL-1b and MCP-1. Our data showed 
that monocytes activated by TNF-α secreted IL-1b and MCP-1 in the culture media.  Next, we 
asked whether this production of IL-1b and MCP-1 was reduced by the inhibition of ACSL1. 
Our data showed that the inhibition of ACSL1 activity in monocytes by triacsin c diminished 
the secretion of IL-1b and MCP-1 (Fig. 2A and B).
ACSL1 deficiency inhibits TNF-α mediated pro-inflammatory shift in monocytes
To further verify TNF-α-induced inflammatory shift in the monocytes was dependent 
on ACSL1, we transfected cells with ACSL1 siRNA (siACSL1), which achieved more than 50% 
reduction in ACSL1 mRNA levels compared with scramble (control) siRNA (Neg-siRNA) (Fig. 
3A). Accordingly, the expression of surface CD16 protein marker was significantly reduced 
in ACSL1 siRNA–transfected cells after stimulation with TNF-α as compared with scramble 
siRNA-transfected cells (Fig. 3B and C). We also noted that CD11c mRNA and protein 
expression was significantly suppressed (P< 0.05) in ACSL1 deficient cells activated with 
TNF-α (Fig. 3D-F). Similarly, CD11b and HLA-DR expression was not upregulated at both 
mRNA and protein levels in ACSL1 deficient cells when activated with TNF-α (CD11b: Fig. 
2G-I; HLA-DR: Fig. 2J-L).
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We additionally wanted 
to know whether TNF-α 
mediated inflammatory effect 
on monocytes was due to the 
modulation in the expression 
of ACSL1. In this regard, the 
cells treated with TNF-α show 
high expression of ACSL1 as 
compared to the controls (Fig. 
4A). ACSL1 siRNA transfection 
suppresses the endogenously 
as well as induced ACSL-1 
expression in monocytic cells 
(Fig. 4B).
Altogether, our results 
show that ACSL1 is a key 
effector of inflammatory 
actions mediated by TNF-α in 
monocytic cells.
Involvement of ACSL1 in 
the TNF-α mediated NF-
кB activation
TNF-α was shown to 
regulate lipid metabolism 
through increasing free 
fatty acids production. This 
process occurs through both 
de-novo and exogenous 
pathways. The increase of 
intracellular concentration 
of fatty acid products such as 
long chain acyl-CoA (LCAC) 
have been shown to induce 
inflammation through NF-κB 
activation [15]. Therefore, we 
questioned whether ACSL1 
is involved in the TNF-α 
mediated activation of NF-
кB. Monocytes treatment 
with TNF-α increased 
phosphorylation of NF-кB 
and it was reduced by the by 
treatment with inhibitor of 
ACSL1 (triacsin c) (Fig. 5A and 
B). Flow cytometric analysis 
of phosphorylated NF-κB P65 
versus its inhibitor protein 
IkBα indicates that, when 
monocytes were stimulated 
with TNF-α, 75.7% of cells 
expressed phosphorylated NF-κB, while only 11.23% of cells had NF-кB in complex form with 
IkBα (Fig. 5C). In contrast pre-treatment of the cells with triacsin c, blocked the translocation 
of NF-κB to the nucleus, where only 5.2% cells showed positive staining for p-NF-κB, while 
Fig. 1. ACSL1 inhibition blocks TNF-α mediated pro-inflammatory 
change in monocytes.  Monocytic cells were pretreated with ACSL1 
inhibitor (Triacsin C: (1uM) or vehicle for 1 hour and then incubated 
with TNF-α for 24 hours. (A, D, G, J) ACSL, CD11c, CD11b and HLA-
DR mRNA were determined by real time RT-PCR. Triacsin C  inhibted 
Cells were stained with antibody against CD16, CD11c, CD11b, or 
HLA-DR, along with matched control antibodies and assessed by flow 
cytometry. (B, E, H, K) Flow cytometry data are presented as a bar 
graph of mean staining intensity (SI) and (C, F, I, L) representative 
histogram. Bar graphs depict mean values ± SEM of staining intensity 
(SI). P<0.05 was considered as statistically significant (* P<0.01; 
**P< 0.001, ***P< 0.0001). The data in all figures are representative 
of three independent experiments.
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the 76.2% cells had NF-кB in a complex form with 
IkBα (Fig. 5C). To further confirm the role of ACSL1 
in TNF-α mediated activation of NF-кB, we used NF-
кB activity reporter monocytic cells. Our data show 
that TNF-α induces higher NF-κB activity in the NF-
кB reporter cells and this activity was not seen in 
the cells treated with ACSL1 inhibitor (triacsin c) 
(Fig. 5D).
To further verify the role of ACSL1 in NF-кB 
activation in TNF-α treated monocytes, ACSL1 
deficient monocytes were generated by using siRNA 
approach. NF-кB phosphorylation effects of TNF-α 
were decreased in ACSL1 deficient cells (Fig. 5E and 
F). Flow cytometric analysis of phosphorylated NF-
κB P65 versus its inhibitor protein IkBα indicates 
that, when ACSL1 deficient cells were stimulated 
with TNF-α, 9.9% of cells expressed positive 
staining for phosphorylated NF-κB, while 88.8% 
cells had NF-кB complexed with IkBα (Fig. 5F).
Discussion
Obesity-induced low grading chronic 
inflammation, a leading cause of insulin resistance, 
is characterized by more activation and infiltration 
of immune cells in peripheral tissues. Among the 
immune cells, monocytes play an important role 
in obesity-induced inflammation and they are 
divided into two classes based on their phenotype 
and function: inflammatory non-classical (M1) 
and classical (M2). The shift in the activation state 
of monocytes from classical (M2) to non-classical 
activated monocytes (M1) is enhanced in obesity. 
These activated monocytes subsequently infiltrate 
and differentiate into M1 macrophages within the 
adipose tissue in response to inflammatory cytokines 
[16, 17].  It is well documented that elevated levels 
of TNF-α in obese humans and rodents influence 
enormously the phenotypic changes occurring in 
monocytes and, also associated with metabolic 
dysfunction and free fatty acids secretion by 
adipocytes. However, the mechanism by which 
TNF-α-induces the inflammatory phenotypic shift 
in monocytes remains elusive. In this study we report that long-chain acyl-CoA synthetase 1 
(ACSL1), a key enzyme of lipid/fatty acids metabolism, is involved in TNF-α-mediated pro-
inflammatory phenotypic shift in monocytes. Our results show that blocking the activity of the 
ACSL1 by triacsin c inhibits the TNF-α induced CD16 expression in monocytes. Furthermore, 
ACSL1 deficiency prevents TNF-α-induced inflammatory switch in monocytes, supporting 
the notion that inflammation induced by TNF-α is reduced by ACSL1 deficiency. CD16 
expression in monocytes is increased in various inflammatory disorders such as coronary 
artery disease, asthma, infection, obesity, and T2D. CD16+ monocytes actively secrete 
inflammatory cytokines [3, 18]. We further explored the impact of ACSL1 on the induction of 
CD11c marker, which is highly expressed on inflammatory monocytes and macrophages in 
Fig. 2. IL-1b and MCP-1 secreted by TNF-α 
activated monocytes are suppressed by 
ACSL1 inhibition. (A and B) Monocytes 
were pretreated with ACSL1 inhibitor 
(triacsin C: (1uM) or vehicle for 1 hour 
and then incubated with TNF-α for 24 
hours. Secreted IL-1b and MCP-1 protein 
in culture media was determined by ELISA. 
All data are expressed as mean ± SEM (n ≥ 
3). *p<0.05, **p<0.01, ***p<0.001 versus 
vehicle.
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obesity setting. We found that interruption of ACSL1 in monocytes diminished the expression 
of CD11c in these cells induced by TNF-α. We also observed the impact of ACSL1 on the 
expression of CD11b and HLA-DR in activated monocytes. It has been reported that mice 
fed on high fat diets had high numbers of CD11c+ monocytes/macrophages, suggesting that 
in obesity state, TNF-α modulates the phenotype of the monocytes/macrophages. Indeed, 
phenotypic switch of monocytes/macrophages in the adipose tissue is a central element of 
metabolic inflammation and insulin resistance in obese mice. CD16+ and CD11c+ monocytes 
are actively involved in the production of inflammatory cytokines and chemokines including 
IL-1b, TNF-α, and MCP-1, pointing to increased migration of the inflammatory monocytes 
from the circulation into adipose tissue in obesity [14, 19]  Our data show that the secretion 
of the IL-1b and MCP-1 by the TNF-α-treated monocytes was significantly blocked by the 
Fig. 3. TNF-α mediated 
p r o - i n f l a m m a t o r y 
phenotypic shift 
requires ACSL1. (A) 
Monocytes were 
transfected with Neg-
siRNA or siACSL1 
siRNA and incubated 
for 36 hours. Real-time 
PCR was performed 
to measure ACSL1 
expression. ACSL1-
deficient cells were 
treated with TNF-α and 
vehicle. (D, G, J) CD11c, 
CD11b, HLA-DR mRNA 
was determined by real 
time RT-PCR. Cells were 
stained with antibody 
against CD16, CD11c, 
CD11b, or HLA-DR, 
along with matched 
control antibody, 
and assessed by flow 
cytometry. (B, E, H, K). 
Flow cytometry data 
are presented as a bar 
graph of mean staining 
intensity (SI) as well as 
(C, F, I, L) representative 
histogram. Bar graphs 
depict mean values 
± SEM of staining 
intensity (SI). P<0.05 
was considered as 
statistically significant 
(* P<0.01; **P< 0.001, 
***P< 0.0001). The 
data in all figures 
are representative of 
three independent 
experiments.
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inhibition of ACSL1. Similarly, ACSL1 deficient cells do 
not show response to TNF-α for the production of IL-
1b and MCP-1. In the case of obesity, IL-1b and MCP-
1 expression appears to be essential for phenotypic 
and functional M1 polarization of monocytes/
macrophages in response to TNF-α. Expression of 
CD16, CD11b, and CD11c correlates with expression 
of IL-1b and MCP1 in inflammatory monocytes. 
It is becoming increasingly clear that monocytes 
isolated from obese humans with diabetes display an 
inflammatory phenotype and secrete higher levels of 
pro-inflammatory mediators such as IL-6, MCP-1, and 
IL-1β. Furthermore, inflammatory monocytes found 
in the setting of obesity and T2D have been shown 
as a result of cytokines/chemokines genes activation 
and metabolic dysfunction. Metabolic dysfunction is 
implicated in a wide-ranging effect on the immune 
cells and release of free fatty acids by adipocytes. Free 
fatty acids exert inflammatory effects in macrophages, 
which could contribute to inflammation in the setting 
of diabetes and associated complications. After 
entering the cell, these fatty acids are thioesterified 
into their acyl-CoA derivatives, a process catalyzed by 
long-chain acyl-CoA synthetases (ACSLs). It has been 
reported that diabetes promotes an inflammatory 
macrophage phenotype through ACSL1. Increased 
expression of ACSL1 is noted in macrophages from 
obese mice and rodents. ACSL1 is upregulated by 
LPS and TNF-α; both are elevated in obesity [8]. We 
also found that ACSL1 expression is high in TNF-α-
activated inflammatory monocytes.
The transcription factor NF-κB induces the 
expression of various pro-inflammatory genes, 
including those encoding cytokines and chemokines. 
Deregulated NF-κB activation contributes to the 
pathogenic processes of various inflammatory 
diseases. NF-κB is involved in polarization and 
differentiation of monocytes into activated state 
implicated in the development of inflammatory 
metabolic diseases [20]. Our results showed that 
deficiency of ACSL1 inhibits the phosphorylation and 
activation of NF-кB in response to TNF-α, indicating a 
very interesting role of ACSL in TNF-α mediated activation of major transcription factor NF-
кB. These results indicate that ACSL1 acts upstream of the NF-κB pathway. These findings 
are consistent with the previous reports indicating that free fatty acid palmitate induces 
proinflammatory cytokine IL-6 production by increasing phosphorylation and transcriptional 
activity of NF-кB protein [21]. It has been reported that siRNA for ACSL3 inhibits palmitate-
induced phosphorylation of p65 subunit of NF-κB and ACSL3 acts upstream of the NF-κB 
pathway. Palmitoyl-CoA or further metabolites of palmitoyl-CoA activates NF-κB signaling 
pathway through the activation of ACSL3 [22]. We further showed that ACSL1 is required in 
TNF-α-driven production of IL-1b and MCP-1. Our results suggested that ACSL1 plays a key 
role in the inflammation induced by TNF-α-activated monocytes.
Fig. 4. Expression level of ACSL1 
is increased TNF-α mediated pro-
inflammatory monocytes. (A) Cells were 
incubated with TNF-α and vehicle for 24 
hours. Cells were harvested and ACSL1 
mRNA was determined by real time RT-
PCR. (B) ACSL-1 deficient monocytic cells 
were treated with TNF-α and vehicle 
for 24 hours. ACSL1 expression was 
determined by real time RT-PCR. The data 
in all figures are representative of three 
independent experiments.
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Fig. 5. NF-кB activation in TNF-α treated monocytes was inhibited by triacsin C or ACSL1 deficiency. 
Monocytic cells were pretreated with ACSL1 inhibitor (Triacsin C: (1uM) or vehicle for 1hr and then 
incubated with TNF-α for 15 minutes. NF-кB phosphorylation was determined by (A) western blotting and 
(B) flow cytometry. (C) Representative flow cytometry dot plots of p-NF-кB fluorescence versus total IkBα 
cells.  (D) NF-кB reporter monocytic cells were pretreated with ACSL1 inhibitor (triacsin C: (1uM) or vehicle 
for 1 hour and then incubated with TNF-α for 24 hours.  Cell culture media were assayed for SEAP reporter 
activity (degree of NF-κB activation). (E) ACSL-1 deficient cells were treated with TNF-α for 15 minutes. 
NF-кB phosphorylation was determined by (E) western blotting and (F) flow cytometry. (G) Representative 
flow cytometry dot plots of p-NF-кB fluorescence versus total IkB α cells. All data are expressed as mean ± 
SEM (n ≥ 3). *p<0.05, **p<0.01, ***p<0.001 versus TNF-α.
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Conclusion
In summary, the results of the present study identify ACSL1 as a relevant contributor to 
the TNF-α-driven pro-inflammatory phenotypic polarization in monocytes. These findings 
could also provide an interesting pathophysiological novel connection between a key enzyme 
of fatty acids metabolism ACSL1 and TNF-α in obesity settings.
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